Tejas Networks completes delivery of 17,000 IP/MPLS routers for BharatNet Phase III
BENGALURU, India, March 30, 2026 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE:…
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
— First randomized Phase III trial confirming the efficacy of MET inhibition…
SOS Limited Announces Development of Tier III Modular Data Center at Longfellow Ranch, Texas
NEW YORK, Dec. 22, 2025 /PRNewswire/ -- SOS Limited (NYSE: SOS) ("SOS"…
InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…
Tejas Networks emerges as a leading supplier of IP Routing products across the country for BharatNet Phase III packages
BENGALURU, India, Dec. 11, 2025 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE:…
Ashika Investment Managers launches Ashika Mid & Small Cap Fund, an open-ended Category III AIF
MUMBAI, India, Dec. 9, 2025 /PRNewswire/ -- Ashika Investment Managers Pvt. Ltd.…
Carl H. Sharperson III Joins MATTER Board of Directors
December 03, 2025 10:00 ET | Source: MATTER MINNEAPOLIS, MN , Dec.…
Sustainable Markets Initiative Hosts Landmark Private Capital Mobilization Convening in London, with a report back session attended by His Majesty King Charles III
LONDON, Dec. 2, 2025 /PRNewswire/ -- Yesterday, the Sustainable Markets Initiative hosted…
Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL)
CHICAGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company…
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…
